Markus Cornberg Selected Research

Markus Cornberg Research Topics

Disease

96	Infections 03/2024 - 02/2002
41	Chronic Hepatitis C 04/2024 - 02/2002
39	Hepatitis C 03/2023 - 07/2004
36	Fibrosis (Cirrhosis) 03/2024 - 01/2014
26	Chronic Hepatitis B 03/2024 - 04/2010
24	Hepatitis B 02/2024 - 04/2010
19	Virus Diseases (Viral Diseases) 04/2024 - 02/2002
17	Liver Diseases (Liver Disease) 03/2024 - 01/2010
14	Chronic Hepatitis (Chronic Active Hepatitis) 05/2024 - 01/2010
14	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 05/2012
13	Hepatitis D 10/2023 - 03/2009
13	Hepatitis 09/2023 - 01/2010
12	Ascites 12/2023 - 01/2017
11	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024 - 01/2010
11	COVID-19 02/2023 - 06/2020
8	Neoplasms (Cancer) 10/2022 - 01/2017
7	Coinfection 02/2024 - 01/2012
6	Chronic Hepatitis D 03/2024 - 01/2023
6	Persistent Infection 03/2024 - 02/2006
6	Disease Progression 10/2023 - 10/2008
4	Portal Hypertension 03/2024 - 01/2021
4	Non-alcoholic Fatty Liver Disease 05/2023 - 12/2016
4	Inflammation (Inflammations) 01/2022 - 01/2010
3	Hemorrhage 12/2023 - 01/2017
3	End Stage Liver Disease 04/2023 - 12/2020
3	Acute Kidney Injury (Acute Renal Failure) 10/2022 - 01/2018
3	Cross Infection (Nosocomial Infection) 01/2022 - 01/2020
2	Brain Diseases (Brain Disorder) 12/2023 - 01/2017
2	Hepatitis E 12/2023 - 01/2020
2	Peritonitis 01/2022 - 01/2018
2	Acute-On-Chronic Liver Failure 01/2022 - 01/2021
2	Convalescence 01/2022 - 01/2021
2	Lymphopenia (Lymphocytopenia) 12/2021 - 01/2021
2	Viremia 01/2021 - 01/2010
2	Communicable Diseases (Infectious Diseases) 01/2021 - 01/2019
2	Hepatitis A (Hepatitis, Infectious) 08/2017 - 12/2006
2	HIV Infections (HIV Infection) 12/2012 - 11/2011

Drug/Important Bio-Agent (IBA)

56	Antiviral Agents (Antivirals)IBA 03/2024 - 12/2002
31	InterferonsIBA 03/2024 - 02/2002
31	RNA (Ribonucleic Acid)IBA 07/2023 - 12/2006
29	Hepatitis B Surface Antigens (HBsAg)FDA Link 04/2024 - 04/2010
21	Ribavirin (Virazole)FDA LinkGeneric 03/2024 - 02/2002
19	AntigensIBA 02/2024 - 06/2006
18	Hepatitis B e AntigensIBA 04/2024 - 04/2010
17	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 12/2009
16	Interferon-alpha (Interferon Alfa)IBA 01/2023 - 02/2002
12	Biomarkers (Surrogate Marker)IBA 11/2022 - 11/2011
12	CytokinesIBA 01/2022 - 10/2011
9	VaccinesIBA 02/2024 - 08/2015
9	Peptides (Polypeptides)IBA 10/2019 - 09/2007
8	EpitopesIBA 05/2023 - 01/2007
7	SofosbuvirIBA 03/2024 - 05/2013
7	BilirubinIBA 01/2020 - 08/2014
6	bulevirtideIBA 05/2024 - 01/2023
6	Tenofovir (Viread)FDA Link 10/2023 - 01/2019
6	Proteins (Proteins, Gene)FDA Link 05/2023 - 10/2004
6	AntibodiesIBA 01/2022 - 01/2010
5	Alanine Transaminase (SGPT)IBA 04/2023 - 02/2016
5	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2022 - 12/2005
5	peginterferon alfa-2a (Pegasys)FDA Link 01/2020 - 10/2015
4	AlbuminsIBA 07/2023 - 08/2014
4	Immunoglobulin G (IgG)IBA 01/2022 - 01/2010
4	glecaprevir and pibrentasvirIBA 01/2022 - 01/2020
3	Interleukin-10 (Interleukin 10)IBA 01/2021 - 10/2002
3	InterleukinsIBA 01/2021 - 10/2011
3	COVID-19 VaccinesIBA 01/2021 - 01/2021
3	ChemokinesIBA 01/2021 - 12/2016
3	LigandsIBA 01/2021 - 05/2010
3	Protease Inhibitors (Protease Inhibitor)IBA 07/2015 - 01/2013
3	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 08/2014 - 02/2012
2	nasIBA 03/2024 - 01/2023
2	HLA Antigens (Human Leukocyte Antigens)IBA 11/2022 - 01/2019
2	Meropenem (Merrem)FDA LinkGeneric 01/2022 - 07/2021
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022 - 01/2020
2	EnzymesIBA 01/2022 - 05/2016
2	Blood Proteins (Serum Proteins)IBA 12/2021 - 12/2016
2	Lymphotoxin-alpha (Lymphotoxin)IBA 01/2021 - 11/2009
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 10/2019
2	Proton Pump InhibitorsIBA 08/2019 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2019 - 10/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2016 - 05/2010
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 11/2015 - 01/2012
2	telaprevirIBA 08/2014 - 01/2013
2	Immunoglobulin M (IgM)IBA 01/2014 - 12/2006
2	peginterferon alfa-2b (Pegintron)FDA Link 06/2013 - 09/2011
2	Natural Killer Cell ReceptorsIBA 05/2012 - 11/2011
2	Interferon alpha-2 (Roferon-A)FDA Link 07/2004 - 12/2002
1	Glycoproteins (Glycoprotein)IBA 04/2024

Therapy/Procedure

72	Therapeutics 04/2024 - 12/2002
17	Liver Transplantation 12/2023 - 10/2006
4	Transplantation 01/2021 - 01/2010
4	Immunotherapy 01/2020 - 05/2011
3	Retreatment 08/2023 - 01/2017
3	Contraindications 07/2023 - 01/2022
3	Surgical Portasystemic Shunt (Portosystemic Shunt) 07/2023 - 01/2020
3	Transjugular Intrahepatic Portasystemic Shunt 01/2022 - 01/2021
3	Aftercare (After-Treatment) 01/2021 - 01/2018
3	Duration of Therapy 01/2020 - 10/2006
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
2	Investigational Therapies (Experimental Therapy) 01/2020 - 11/2019